J&J agrees to settlement with two Ohio counties ahead of opioid trial

Johnson & Johnson (NYSE:JNJ) says it will pay a $20.4M settlement with Cuyahoga and Summit counties in Ohio that accused it of contributing to the U.S. opioid addiction epidemic.

JNJ says the deal resolves all of the counties’ claims with no admission of liability and removes the company from a federal trial scheduled to begin Oct. 21.

Yesterday, Mallinckrodt (NYSE:MNK) announced a $24M settlement with the same two counties, and Endo International (NASDAQ:ENDP) and Allergan (NYSE:AGN) had settled with the counties in August to avoid going to trial.

Remaining defendants in the Oct. 21 trial include McKesson (NYSE:MCK), AmerisourceBergen (NYSE:ABC), Cardinal Health (NYSE:CAH), Teva Pharmaceutical (NYSE:TEVA), Walgreens Boots Alliance (NASDAQ:WBA) and Henry Schein (NASDAQ:HSIC).

JNJ and most of the other companies still face thousands of lawsuits related to the opioid epidemic.


READ  BP's legendary chief Lord Browne makes a return to the oil business with a £23bn float on the cards


Please enter your comment!
Please enter your name here